Jounce Therapeutics, Inc.
Antibodies to LILRB2
Last updated:
Abstract:
Provided herein are various embodiments relating to antibodies that bind LILRB2. Anti-LILRB2 antibodies can be used in methods to treat disease, for example, cancer.
Status:
Grant
Type:
Utility
Filling date:
20 Dec 2018
Issue date:
28 Jul 2020